#Defence Production Act (DPA) | Explore Tumblr posts and blogs

premimtimes · 4 years ago

Text

Lessons of the COVID-19 Pandemic For Our Collective Humanity, By Femi Falana

COVID Vaccine In sum, the response to the crisis should, therefore, be based on the principles of compassion, cooperation and multilateralism. In fact, apart from the pandemic, other global issues such as climate change, social inequality, drugs and identity crisis require cooperation and multilateral approaches because they constitute dangers to our common humanity. The most telling lesson of…

View On WordPress

#EndSARS protests #Coalition Against COVID (CACOVID)#Covid-19 #COVID-19 Vaccines Global Access (COVAX)#cuba #Defence Production Act (DPA)#Dr Ngozi Okonjo Iweala #Femi Falana #Global Alliance for Vaccines and Immunisations (GAVI)#President Donald Trump #President Joe Biden #Serum Institute of India (SII)#Vaccine Nationalism #Vaccines #World Health Organisation (WHO)#World Trade Organisation (WTO)

0 notes

etirabys · 4 years ago

Link

That was shortly after the Biden administration announced, on February 5th, plans to use the Defence Production Act (DPA)—a law dating from the 1950s that grants the president broad industrial-mobilisation powers—to bolster vaccine-making. This legislation, previously invoked for similar reasons by Donald Trump when he was president, has helped American pharmaceutical companies to secure a variety of special materials and equipment, including plastic tubing, raw goods, filters and even paper, that are needed for vaccine production. But firms which export such products point out that the DPA hinders their ability to sell them abroad. They must seek permission before exporting these goods. That requires time and paperwork. And if the government decides it needs the goods in question to remain in the country, the firms concerned may be barred from exporting them at all.

On March 24th Micheal Martin, Ireland’s prime minister, warned that export bans (and not just from America) would harm global vaccine production. He noted that the Pfizer vaccine involves 280 components from 86 suppliers in 19 countries. Indeed, American export controls particularly harm European vaccine companies, which need special bags from America in which to make their products. At a vaccine supply-chain meeting in March, one such firm complained of 66-week delivery times for the supply of these bags.

Sai Prasad, head of the Developing Countries Vaccine Manufacturers Network, says the DPA and any other export restrictions will be a serious impediment to the ability of the industry to make and supply vaccines. He observes that making a batch of vaccine can take between 60 and 180 days. Disruptions in raw materials, packing materials and single-use consumables will thus lead to disproportionately longer delays. In short, vaccine production lines cannot come to a halt and then start up again quickly. The consequence of a missing item could be a disruption in supply which is felt for months.

MarginalRevolution post that links to the above:

I want to point to a foreign policy disaster in the making. America’s role as the guarantor of a globalized, mostly peaceful, and orderly world–already deeply hurt by four years of “America First,”–is now under further threat by an increasing perception that we are vaccine hoarders. ... A shutdown of vaccine production in India would be a disaster for India and also for the United States. Our image in Asia will be tarnished at a time when we want to be making allies to counter Chinese influence.

#covid19 #sampl

31 notes · View notes

digitalfime · 4 years ago

Text

US should grant India special waiver from DPA for vaccine raw materials

The United States ought to consider granting India a special exemption or waiver from the imposition of its Defence Production Act (DPA) on raw materials for Indian vaccine manufacturers. This would probably be the clearest and most durable way forward on an issue, which if not resolved, could adversely impact Indian plans to ramp up vaccine production. At present, there’s considerable confusion…

View On WordPress

0 notes

ezhilmozhi · 4 years ago

Text

When asked when the Biden administration would decide on India’s request to lift a ban on the export of vaccine raw materials, State Department spokesperson Ned Price said: “...the United States first and foremost is engaged in an ambitious and effective and, so far, successful effort to vaccinate the American people.”

“That campaign is well underway, and we’re doing that for a couple of reasons. Number one, we have a special responsibility to the American people. Number two, the American people, this country has been hit harder than any other country around the world – more than 550,000 deaths, tens of millions of infections in this country alone,” he said on Thursday.

It is not only in the U.S. interest to see Americans vaccinated; but it is in the interests of the rest of the world to see Americans vaccinated, he said.

“The point the Secretary (of State Antony Blinken) has made repeatedly is that as long as the virus is spreading anywhere, it is a threat to people everywhere. So as long as the virus is spreading uncontrolled in this country, it can mutate and it can travel beyond our borders. That, in turn, poses a threat well beyond the United States,” Mr. Price said in responses to questions.

As for the rest of the world, “We will, of course, always do as much as we can, consistent with our first obligation,” he said.

India is currently facing a horrible surge in coronavirus infections. The country on Friday added a record over 3.32 lakh new coronavirus cases in a single day taking the country’s tally to 1,62,63,695, while active cases crossed the 24-lakh mark.

The Biden administration recently conveyed to New Delhi that it understands India’s pharmaceutical requirements and promised to give the matter due consideration.

It observed that the current difficulty in the export of critical raw materials needed to manufacture COVID-19 vaccines is mainly due to an Act that forces American companies to prioritise domestic consumption.

President Joe Biden and his predecessor Donald Trump had invoked the war-time Defence Production Act (DPA) that leaves U.S. companies with no option but to give priority to the production of COVID-19 vaccines and Personal Protective Equipment (PPEs) for domestic production to combat the deadly pandemic in America, the worst-hit nation.

The U.S. has ramped up the production of COVID-19 vaccines mostly by Pfizer and Moderna to meet the goal of vaccinating its entire population by July 4.

The suppliers of its raw materials, which is in high demand globally and sought after by major Indian manufacturers, are being forced to provide it only for domestic manufacturers in the U.S.

The Serum Institute of India is the world’s largest producer of the COVID-19 vaccine.

In recent weeks, India’s Ambassador to the U.S. Taranjit Singh Sandhu has been taking up the matter with the Biden administration officials.

During the telephonic conversation between U.S. Secretary of State Blinken and External Affairs Minister S. Jaishankar, the two top diplomats also discussed the coronavirus pandemic and ways to deal with it.

State Department spokesperson Mr. Price said the U.S. has played a leadership role when it comes to containing, seeking to contain the virus beyond its borders.

“We have re-engaged with the WHO on day one, the $2 billion we’ve contributed to COVAX, with 2 billion more on the way. When it comes to our own hemisphere, the loan arrangement with Canada and Mexico, and when it comes to India, the Quad and the arrangement with the Quad, including to increase production capacity in India,” he said.

“So as we are more comfortable in our position here at home, as we are confident that we are able to address any contingencies as they may arise, I expect we’ll be able to do more,” he said.

#charity begins at home #for Americans wondering why the global South is leery of the USA #vaccine hesitancy #vaccine #Biden takes the adage to new dimensions

0 notes

willpony · 6 years ago

Photo

國防廠商的分級制度涉綁標？學者：恐是多慮立法院民進黨團日前以優先法案之姿，透過強勢表決在立法院三讀通過「國防產業發展條例」，創設「廠商分類分級」制，授權國防部將國內國防產業相關廠商分類分級，並作為廠商接受獎勵、是否優先被採購、優惠與協助，與擔任指定研發商的標準，引發質疑。有學者認為，將國防廠商的分級制度與綁標問題混為一談，恐是多慮。國防院國防產業所長蘇紫雲受訪表示，國防廠商的分級制度，除了參考個民主國家的常態作法外，在一般業界，無��是公私部門，對供應商、服務商的分級也是正規作法。以金融業為例，國內合格的信用卡、金融卡等晶片卡供應商，都需經過相關的資格認證、包括生產機具、資訊設備安管、部門區隔、甚至人員動線的授權管理等都需認證才能取得不同的供應資格。他說，即使是國人每天的食品，廠商也須依照食品法規取得認證，以確保食品安全。因此國防產業的認證也是同樣精神，且依照目前的國際趨勢觀察，供應鏈安全將是安防市場進入的關鍵，對推動台灣國防產業與國際市場接軌即為重要。蘇紫雲表示，此法基本精神類似美國的「國防裝備法」Defense Production Act (DPA)，用以規範軍事裝備的生產與採購。川普政府在2018年並予以修訂，以契合美國現況，企圖將軍備需求與國內產業密切結合。類似的政策，包括北約的「智慧國防」(smart defence policy)、美國的「抵消戰略」(offset strategy)、中共的「軍民融合」等，將國防預算的支出，創造國內經濟產值。他說，國防經濟效益，依照美國、法國、日本、澳洲的公開資料，軍事裝備能創造「經濟加乘」(multiplier effect )效果，約在1.7 至 3.2倍之間。台灣的「國防產業產業發展條例」主要規範軍品分級、產業參與的資格、安全查核等，符合各國相關政策與法規的法意。蘇紫雲進一步說，由該條例看來，類似不同業種常見的分級規範，如「甲/乙級營造廠」、「甲/乙級環保廠」的資格規範與管理方式，以國防產業屬機敏性製造業觀察，國防產業條例可說合理。未來需補強的部份，或可參考美國防部採購規範，包括職業退役軍人、少數民族、女性企業主的公司，以及中小企業、新創企業等，在國防採購計畫中，可享有一定比例的優先權，或是在大型廠商得標的軍事採購案中，規範需將一定比例的得標金額轉包予前述弱勢企業，以保障並鼓勵國防產業的多元化。

0 notes

courtneytincher · 5 years ago

Text

Pentagon to ramp up N95 mask production by over 39 million over the next 90 days

The U.S. Department of Defense using Defense Production Act authority to ramp up N95 mask production, according to Lt. Col. Mike Andrews, Department of Defense spokesman.

$133 million investment will increase U.S. domestic N95 respirator mask production by over 39 million over the next 90 days

“On the evening of April 10, the Department of Defense received approval from the White House Task Force to execute the first DPA Title 3 project responding to COVID-19.

The $133 million project will use these authorities to increase domestic production capacity of N95 masks to over 39 million in the next 90 days.

The increased production will ensure the U.S. Government gets dedicated long term industrial capacity to meet the needs of the nation.

Additional details, including the names of the companies, will be provided in the coming days when the contract is awarded.

N95 masks have been seen as a critical resource and the Defense Department has already pledged 10 million such masks from its own stockpiles to the Department of Health and Human Services.

An N95 respirator is a respiratory protective device designed to achieve a very close facial fit and very efficient filtration of airborne particles.

The ‘N95’ designation means that when subjected to careful testing, the respirator blocks at least 95 percent of very small (0.3 micron) test particles. If properly fitted, the filtration capabilities of N95 respirators exceed those of face masks. However, even a properly fitted N95 respirator does not completely eliminate the risk of illness or death.

If worn properly, an N95 mask is meant to help block large-particle droplets, splashes, sprays, or splatter that may contain germs (viruses and bacteria), keeping it from reaching your mouth and nose. N95 masks may also help reduce exposure of your saliva and respiratory secretions to others.

from Defence Blog